Solid Tumor FFPE
Cytogenetics: Karyotyping (Oncology) - Fresh Surgical tumor biopsy
| FISH | Molecular genetics | NGS |
|---|---|---|
| HER2 ERBB2 PathVysion FDA approved | EGFR | NGS Oncomine Comprehensive 161 genes DNA + RNA |
| ALK | KRAS | |
| ROS1 | NRAS | NGS Oncomine BRCA Assay Somatic analysis |
| EGFR HER1 | BRAF | NGS Oncomine BRCA Assay Germline analysis |
| FGFR1 | C KIT | |
| FGFR2 | PIK3CA | |
| FGFR3 | MGMT | |
| 1p / 19q | IDH1 / IDH2 | |
| MYC | BRCA1 CNV | |
| BCL1 (CCND1) | BRCA2 / CHEK2 CNV | |
| BCL2 | TP53 Sequencing | |
| BCL6 | MET exon 14 skipping mutations (RNA) | |
| IGH | RET (RNA) | |
| EWSR1 | MET exon 14 skipping mutations (RNA) | |
| FUS | ALK (RNA) | |
| FOXO | ROS1 (RNA) | |
| NMYC | MSI | |
| NTRK1 | ||
| NTRK2 | ||
| NTRK3 | ||
| RET | ||
| MET | ||
| NRG1 | ||
| PDL1 / PDL2 | ||
| BRCA1 / BRCA2 | ||
| SS18 | ||
| c-MYC / BCL2 / BCL6 (double / Triple Hit Lymphoma) |